BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15567300)

  • 1. Permeability modulation of human intestinal Caco-2 cell monolayers by interferons.
    Kawaguchi H; Akazawa Y; Watanabe Y; Takakura Y
    Eur J Pharm Biopharm; 2005 Jan; 59(1):45-50. PubMed ID: 15567300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
    Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
    J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of benzo[a]pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer.
    Sugihara N; Toyama K; Michihara A; Akasaki K; Tsuji H; Furuno K
    Toxicology; 2006 Jun; 223(1-2):156-65. PubMed ID: 16647797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
    Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
    J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing effect of N-octyl-O-sulfate chitosan on etoposide absorption.
    Mo R; Xiao Y; Sun M; Zhang C; Ping Q
    Int J Pharm; 2011 May; 409(1-2):38-45. PubMed ID: 21356302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of hop bitter acids across intestinal Caco-2 cell monolayers.
    Cattoor K; Bracke M; Deforce D; De Keukeleire D; Heyerick A
    J Agric Food Chem; 2010 Apr; 58(7):4132-40. PubMed ID: 20329731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport characteristics of rutin deca (H-) sulfonate sodium across Caco-2 cell monolayers.
    He Y; Zeng S
    J Pharm Pharmacol; 2005 Oct; 57(10):1297-303. PubMed ID: 16259758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
    J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of the naringin low uptake by intestinal Caco-2 cells.
    Tourniaire F; Hassan M; André M; Ghiringhelli O; Alquier C; Amiot MJ
    Mol Nutr Food Res; 2005 Oct; 49(10):957-62. PubMed ID: 16189799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone inhibits rhodamine123 transport in Caco-2 cells.
    Störmer E; Perloff MD; von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 2001 Jul; 29(7):954-6. PubMed ID: 11408360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nonylphenol ethoxylates (NPEs) on barrier functions of epithelial cell membranes: opening of tight junctions and competitive inhibition of P-gp-mediated efflux.
    Doo MH; Li H; Jang HI; Song IS; Chung SJ; Shim CK
    Int J Pharm; 2005 Sep; 302(1-2):145-53. PubMed ID: 16111844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
    Arima H; Yunomae K; Hirayama F; Uekama K
    J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.
    Yu L; Zeng S
    J Pharm Pharmacol; 2007 May; 59(5):655-60. PubMed ID: 17524230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products.
    Yoshida N; Koizumi M; Adachi I; Kawakami J
    Food Chem Toxicol; 2006 Dec; 44(12):2033-9. PubMed ID: 16904803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of citrus fruit juices on cytotoxicity and drug transport pathways of Caco-2 cell monolayers.
    Lim SL; Lim LY
    Int J Pharm; 2006 Jan; 307(1):42-50. PubMed ID: 16260103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
    Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
    Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
    Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; Gefroh HA; Devane CL
    J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Absorption of papaverine, laudanosine and cepharanthine across human intestine by using human Caco-2 cells monolayers model].
    Ma L; Yang XW
    Yao Xue Xue Bao; 2008 Feb; 43(2):202-7. PubMed ID: 18507350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
    Ingels F; Beck B; Oth M; Augustijns P
    Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of conjugated linoleic acid and medium-chain fatty acids on transepithelial calcium transport in human intestinal-like Caco-2 cells.
    Jewell C; Cashman KD
    Br J Nutr; 2003 May; 89(5):639-47. PubMed ID: 12720584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.